November 2009 Volume 5, Issue 11
Volume 5, Issue 11 | November 2009
November 2009
In this Issue
Genomics & Proteomics
Big Blue goes after holy grail
IBM aims to achieve the $1,000 genome goal by running DNA through its computer chip-like DNA TransistorA good match for sequencing
Life Technologies and febit team up to provide resequencing products and servicesRight on target
Roche and SAIC-Frederick partner on targeted resequencing of cancer genesThe pathway less traveled
TGen, Scottsdale Healthcare researchers use computer simulations to validate treatment targets for lung cancerStudy and re-study
Wayne State, U of Michigan partner with Toronto hospital on childhood OCD researchGlobal News
sanofi-aventis sees eye-catching deal
French pharma acquires ophthalmology-focused Fovea Pharmaceuticals for $543 millionBig Pharma under fire
European regulators raid top pharmas for suspected antitrust activityA blossoming diagnostic duo
Qiagen acquires DxS in deal worth up to $130 millionBitten by the ‘kissing bug’
Eisai and DNDi to collaborate on a new drug for Chagas diseaseSwiss companies aiming for peptide pinnacle
mondoBIOTECH and Bachem sign long-term deal aimed at fighting rare diseasesResearch & Development
Taking a stake
Johnson & Johnson invests $444 million in Crucell to develop therapies for influenza and other diseasesTotal knockout of Parkinson's
Michael J. Fox Foundation, Sigma-Aldrich researchers count on knockout rats to deliver a KO punch to Parkinson's diseaseGen-Probe spreads infectious disease reach
Company agrees to acquire molecular testing company Prodesse in $60 million cash deal, plus more in milestonesOncology research hits the Outback
Australia’s Cancer Therapeutics collaborates with Duke University to develop cancer drug therapiesBenefiting from BPM
Savvion-Patni Life Sciences CRO partnership focuses on delivering business process management-enabled servicesInformatics
Australian researchers: G'day, pathways
QFAB selects Ingenuity Systems' IPA in multiyear deal for systems biology effortUnity in sequencing
CLC bio scores two collaboration deals integrating its technology with that of BIOBASE and GenoLogicsBioClinica adds another piece to the pie
Company acquires supply chain simulation and parameter-driven interactive voice and web response technology (IXR) developer Tortellotte to add to its e-clinical servicesPlaying in Europe now
Phase Forward inks multi-year data management agreement with European pharma Gedeon RichterKendle adds OmniComm’s TrialMaster EDC solution to e-clinical offerings
Leading global CRO Kendle announced in October that it will add OmniComm’s TrialMaster EDC solution to its current e-clinical offerings in a multi-year enterprise-wide agreement.New Products
System combines top-down and bottom-up proteomics to improve biomarker discovery
Bio-Rad Laboratories Inc. and Bruker Corp. have jointly launched the Lucid Proteomics System, the first system to combine top-down and bottom-up proteomics approaches for biomarker discovery.Membrane adsorber for hydrophobic interaction chromatography
Sartorius Stedim Biotech has launched the first commercially available membrane adsorber for hydrophobic interaction chromatography (HIC). Sartobind Phenyl membrane adsorbers allow increased flow rates to ensure faster processes and can be used for process upgrades in purification and polishing of therapeutic proteins.Fast, efficient and competitive pipetting
CyBi-SELMA is a semi-automatic pipettor that is fast, precise and robust. With 96 disposable tips, all 96- and 384-well microplate formats can be filled in seconds.Commentary
Warning: Out of focus and multitasking
Focus is my favorite business word and my most challenging objective. We know from established science that multitasking doesn't work. It is dangerous in moving vehicles and not too effective in classrooms, business or government.Translating between preclinical data and clinical outcomes: The bottleneck is always on the other side
You can have the best tools possible, but if you don’t have the skills to use them—or don’t fully understand the question at hand—there will always be a bottleneck on one side or another.Editor's Focus
On your mark, get set … the race for the $1,000 genome heats up
Who will be the first to cross the finish line in the race to achieve the $1,000 genome? Our cover story details how the latest entrant in this quest, IBM, is developing a technology that the computer technology giant believes could put it in front of the international race to drive down the cost of gene sequencing.Automation & Instrumentation
MPI imaging technology aims at human application
Philips and Bruker BioSpin to develop new magnetic particle imaging scanners for the preclinical marketWhere the hardware meets wetware
Enzo Biochem and BioTek Instruments collaborate on development of system for the study of live cellsArrestin developments
DiscoveRx signs worldwide agreement to provide GSK with access to PathHunter _-Arrestin cell lines and reagents for GPCR screeningAmped-up MDx assays
Quidel, BioHelix in deal to develop in vitro molecular diagnostic testsFeature
Publisher's note: 'Tis the season to reflect on the year's blessings
ddn blessed with continued growth and expansion this Thanksgiving
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Thermo Scientific™ Centrifuges with GreenCool Technology
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
